The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.
作者信息
Perry F E, Catterall J R
出版信息
Thorax. 1994 Oct;49(10):946-50. doi: 10.1136/thx.49.10.946.
Abstract
摘要
相似文献
1
The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.肺炎链球菌：宿主与病原体的相互作用及其对免疫治疗和免疫预防的意义。
Thorax. 1994 Oct;49(10):946-50. doi: 10.1136/thx.49.10.946.
2
[Pneumococcal infections].
Minerva Med. 1983 Apr 14;74(16):901-12.
3
4
[Pneumococcal pneumonia: epidemiology, therapy, immunoprophylaxis].[肺炎球菌肺炎：流行病学、治疗、免疫预防]
Schweiz Med Wochenschr. 1980 Aug 30;110(35):1258-65.
5
[Protective vaccination against pneumococci].
Pneumologie. 2000 Jul;54(7):287-8. doi: 10.1055/s-2000-4453.
6
Immunoprophylaxis of pneumococcal pneumonia.
W V Med J. 1979 Dec;75(12):357-9.
7
Pneumococcal polysaccharide immunization.肺炎球菌多糖免疫接种
West J Med. 1984 Jun;140(6):930-1.
8
Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.用非包膜肺炎链球菌的肺炎球菌表面蛋白K进行免疫接种可在小鼠定植模型中提供保护。
Clin Vaccine Immunol. 2015 Nov;22(11):1146-53. doi: 10.1128/CVI.00456-15. Epub 2015 Aug 26.
9
Fatal pneumococcal infection: another plea for the pneumococcal vaccine.
N Y State J Med. 1991 Jan;91(1):36.
10
Pneumococcal vaccine -- a surgeon's overview.
Am J Surg. 1979 Mar;137(3):283-4. doi: 10.1016/0002-9610(79)90053-9.
引用本文的文献
1
Streptococcus pneumoniae.肺炎链球菌
Thorax. 1999 Oct;54(10):929-37. doi: 10.1136/thx.54.10.929.
本文引用的文献
1
Toxicity of pneumococcal neuraminidase.肺炎球菌神经氨酸酶的毒性。
Infect Immun. 1970 Jul;2(1):115-7. doi: 10.1128/iai.2.1.115-117.1970.
2
PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.肺炎球菌血症，特别是关于菌血症性肺炎球菌肺炎
Ann Intern Med. 1964 May;60:759-76. doi: 10.7326/0003-4819-60-5-759.
3
The in vivo antibody response in rat gut-associated lymphoid tissue (GALT) after immunization with bacterial polysaccharide antigen.
Res Immunol. 1993 Feb;144(2):121-8. doi: 10.1016/0923-2494(93)80067-9.
4
Immunization of mice with Salmonella typhimurium C5 aroA expressing a genetically toxoided derivative of the pneumococcal toxin pneumolysin.用表达肺炎球菌毒素溶血素基因类毒素衍生物的鼠伤寒沙门氏菌C5 aroA对小鼠进行免疫接种。
Microb Pathog. 1993 Feb;14(2):95-102. doi: 10.1006/mpat.1993.1010.
5
Cytokines, sepsis and immunomodulation.细胞因子、脓毒症与免疫调节
Br J Surg. 1993 Mar;80(3):289-97. doi: 10.1002/bjs.1800800308.
6
From the National Institutes of Health.
JAMA. 1993 Apr 7;269(13):1612. doi: 10.1001/jama.269.13.1612.
7
Immunologic therapy for ARDS, septic shock, and multiple-organ failure.针对急性呼吸窘迫综合征、感染性休克和多器官功能衰竭的免疫治疗。
Chest. 1993 Mar;103(3):932-43. doi: 10.1378/chest.103.3.932.
8
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.抗肿瘤坏死因子单克隆抗体对脓毒症患者细胞因子水平的影响。CB0006脓毒症综合征研究组。
Crit Care Med. 1993 Mar;21(3):318-27. doi: 10.1097/00003246-199303000-00006.
9
Active immunisation and resistance to experimental acute pneumococcal otitis media.
Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):91-103. doi: 10.1016/0165-5876(93)90013-s.
10
Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.肺炎球菌荚膜多糖-脑膜炎球菌外膜蛋白复合物结合疫苗：在实验性肺炎球菌性中耳炎中的免疫原性和疗效
J Infect Dis. 1993 Feb;167(2):347-55. doi: 10.1093/infdis/167.2.347.
Zotero 插件